zolpidem tartrate 6.25 mg
1 INDICATIONS AND USAGE Zolpidem tartrate extended-release tablets are indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset). The clinical trials performed in support of efficacy were up to 3 weeks (using polysomnography measurement up to 2 weeks in both adult and elderly patients) and 24 weeks (using patient-reported assessment in adult patients only) in duration [see Clinical Studies (14) ]. Zolpidem tartrate extended-release tablets, a gamma-aminobutyric acid (GABA) A receptor positive modulator, is indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. ( 1 )
breckenridge pharmaceutical, inc.
ROUND PINK T
T ROUND PINK
Related Pills
zolpidem tartrate 12.5 mg
breckenridge pharmaceutical, inc.
Aspirin 325 MG Delayed Release Oral Tablet
aphena pharma solutions - tennessee, llc
theraflu severe cold relief soft chews acetaminophen dextromethorphan hbr tablet chewable
haleon us holdings llc
tums chewy bites mixed fruit calcium carbonate 1 g
glaxosmithkline consumer healthcare holdings
calcium carbonate 750 mg
glaxosmithkline consumer healthcare holdings
Acetaminophen 650 mg Hydrocodone 10 mg
watson laboratories, inc.
APAP 325 MG hydrocodone bitartrate 5 MG Oral Tablet
Watson Laboratories, Inc.
APAP 325 MG tramadol hydrochloride 37.5 MG Oral Tablet
Mylan Pharmaceuticals Inc.
Guaifenesin 400 MG Oral Tablet
Sunrise Pharmaceutical Inc
tamsulosin hydrochloride 0.4 MG Modified Release Oral Capsule
PD-Rx Pharmaceuticals, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
ZOLPIDEM TARTRATE extended-release tablets, USP 6.25 mg are composed of two layers Layers are covered by the coating and are indistinguishable. and are pink, round, coated tablets debossed with "T" one side and plain on other side and supplied as: NDC Number Size 51991-981-01 bottle of 100
ZOLPIDEM TARTRATE extended-release tablets, USP 12.5 mg are composed of two layers and are blue, round, coated tablets debossed with "Z" one side and plain on other side and supplied as: NDC Number Size 51991-982-01 bottle of 100 Store between 15°C–25°C (59°F–77°F). Limited excursions permissible up to 30°C (86°F).
More pills like ROUND T